Improved Efficacy of a Pegylated Interferon-α-2a Stepwise Optimization Treatment Strategy in the Treatment of Hepatitis B e Antigen-positive Chronic Hepatitis B Patients

Current pegylated interferon-α (PEG-IFN) treatment for chronic hepatitis B (CHB) e-antigen (HBeAg)-positive patients are suboptimal, and effective ways of improving PEG-IFN treatment efficacy are needed. This retrospective cohort study compared the efficacy of a PEG-IFN stepwise optimization treatme...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Medicine (Baltimore)
Auteurs principaux: Zhou, Pu, Yang, Feifei, Wang, Jinyu, Mao, Richeng, Qi, Xun, Huang, Yuxian, Zhang, Jiming
Format: Artigo
Langue:Inglês
Publié: Wolters Kluwer Health 2015
Sujets:
4500
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4603052/
https://ncbi.nlm.nih.gov/pubmed/25929904
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000000730
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires